GSK2334470, also known as GSK-2334470 CAS: 1227911-45-6, is a chemical compound that has gained significant attention in recent years for its potential health benefits. This product is primarily known as an inhibitor of the serine/threonine kinase 11 (STK11) pathway, which may have implications for the treatment of various diseases. In this article, we will explore the chemical properties of GSK2334470, its potential health benefits, safety considerations, and dosing information.
Chemical name:
The chemical name for GSK2334470 is (2R)-2-benzyl-3-(4-fluorophenylamino)-N-(pyridin-3-yl)propanamide.
Molecular formula:
The molecular formula of GSK2334470 is C22H20FN3O.
Formula weight:
The molecular weight of GSK2334470 is 369.42 g/mol.
CAS No:
The CAS number for GSK2334470 is 1227911-45-6.
Top ten keywords from Google and Synonyms Synonym:
Health benefits of this product:
GSK2334470 has been found to have a variety of potential health benefits. One of the most studied applications of this compound is in the treatment of cancer. Specifically, GSK2334470 may be effective in treating lung cancer. Studies have shown that GSK2334470 can inhibit the growth of lung cancer cells by activating the AMP-activated protein kinase (AMPK) pathway, which plays an important role in cellular metabolism and energy balance.
In addition to cancer treatment, GSK2334470 may also have potential in the treatment of other conditions related to cellular metabolism and autophagy. These conditions include diabetes, obesity, and neurodegenerative disorders such as Parkinson's disease.
Potential effects:
GSK2334470 works by inhibiting the activity of the STK11 pathway. The STK11 pathway is involved in a variety of cellular processes, including tumor suppression, cellular metabolism, and autophagy. By inhibiting this pathway, GSK2334470 may be able to influence these processes and potentially affect the development and progression of various diseases.
Product mechanism:
The precise mechanism of action of GSK2334470 is not well understood, but it is believed to work by binding to and inhibiting the activity of the STK11 enzyme.
Safety:
GSK2334470 is generally considered to be safe when used as directed. However, as with any medication or supplement, there is some risk of side effects. It is important to consult with a healthcare provider before using GSK2334470, especially if you have any underlying medical conditions or are taking other medications.
Side effects:
Some potential side effects of GSK2334470 include nausea, vomiting, fatigue, and diarrhea. More serious side effects may include liver toxicity and blood disorders. If you experience any of these symptoms or other severe side effects, you should seek medical attention immediately.
Dosing information:
The optimal dosage of GSK2334470 will depend on the specific application and the individual's needs. It is important to follow the dosing instructions provided by a healthcare provider or on the product label. In general, doses of GSK2334470 in the range of 5-30 mg/kg per day have been used in animal studies.
Conclusion:
GSK2334470 is a promising compound with potential health benefits in the treatment of cancer, metabolic disorders, and neurodegenerative diseases. Its mechanism of action through the inhibition of the STK11 pathway is a promising avenue for new drug therapies. While generally safe, it is important to consult with a healthcare provider before using GSK2334470 and to follow dosing instructions carefully. Further research is needed to fully understand the potential benefits and risks of this compound
